Atasayar, G. Et Al. 2016. Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.. Journal of the neurological sciences , vol.366 , 149-154.

Atasayar, G., Eryılmaz, I. E., Karli, N., Egeli, Ü., Zarifoğlu, M., Çeçener, G., ... Taskapilioglu, O.(2016). Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.. Journal of the neurological sciences , vol.366, 149-154.

Atasayar, Gulfer Et Al. "Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.," Journal of the neurological sciences , vol.366, 149-154, 2016

Atasayar, Gulfer Et Al. "Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.." Journal of the neurological sciences , vol.366, pp.149-154, 2016

Atasayar, G. Et Al. (2016) . "Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.." Journal of the neurological sciences , vol.366, pp.149-154.

@article{article, author={Gulfer Atasayar Et Al. }, title={Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.}, journal={Journal of the neurological sciences}, year=2016, pages={149-154} }